Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1

BACKGROUND: Androgen deprivation therapy (ADT) is the main clinical treatment for patients with advanced prostate cancer (PCa). However, PCa eventually progresses to castration‐resistant prostate cancer (CRPC), largely because of androgen receptor variation and increased intratumoral androgen synthe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Transl Med
Asıl Yazarlar: Zhou, Lijie, Zhang, Cai, Yang, Xiong, Liu, Lilong, Hu, Junyi, Hou, Yaxin, Tao, Hong, Sugimura, Haruhiko, Chen, Zhaohui, Wang, Liang, Chen, Ke
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2021
Konular:
Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8181204/
https://ncbi.nlm.nih.gov/pubmed/34185414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ctm2.449
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller